• Vera Therapeutics granted inducement awards on May 4, 2026 to 10 new employees, covering stock options for 40,250 shares of Class A common stock plus RSUs for 20,125 shares under its 2024 Inducement Plan.
• Stock options carry an exercise price of $35.51 per share, set at closing price on May 4, 2026.
• Options vest over four years, with 25% vesting on first anniversary of vesting start date, remainder vesting monthly over next 36 months.
• RSUs vest over four years, with 25% vesting on each anniversary of May 20, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vera Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605081605PRIMZONEFULLFEED9715652) on May 08, 2026, and is solely responsible for the information contained therein.